Skip to main content

NEWS

Updates on OXGENE's Discovery and Biomanufacturing technologies

Opinion, insight and interviews: the latest articles from across OXGENE

Upcoming events, webinars, conferences

WuXi AppTec acquire OXGENE

02 March 2021

WuXi AppTec acquire OXGENE

WuXi AppTec Completes Acquisition of OXGENE to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers PHILADELPHIA and OXFORD, March 2, 2021 - WuXi AppTec, a leading...

View Details
Introducing SLIM display

Introducing SLIM display

12 Jan 2021
TESSA Technology Launch

TESSA Technology Launch

22 Sep 2020
OXGENE reports 100% revenue growth

OXGENE reports 100% revenue growth

06 May 2020
Fujifilm Partnership

Fujifilm Partnership

23 Apr 2020
The Native Antigen Company Collaboration

The Native Antigen Company Collaboration

02 Apr 2020
Vaccitech License

Vaccitech License

08 Jan 2020
First license in Asia

First license in Asia

11 Dec 2019
Abcam agreement

Abcam agreement

25 Sep 2019
OXGENE brand launch

OXGENE brand launch

10 Sep 2019
Cell and Gene Therapy Catapult collaboration

Cell and Gene Therapy Catapult collaboration

13 May 2019
New Investment

New Investment

28 Mar 2019
Aldevron interview

Aldevron interview

01 Mar 2019
×